17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers 
The 33rd Hong Kong International Optical Fair attracts some 12,000 buyers 
TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever 
KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or…
Oyster Point Pharma Provides Key Supply Chain Insight For OC-01 (varenicline) Nasal Spray
PRINCETON, N.J., June 29, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), today…
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated…
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
PALISADE-1 Phase 3 trial underway to evaluate PH94B for rapid-onset acute treatment of anxiety in…
Eledon Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
IRVINE, Calif., June 29, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Motus GI to Present at the Ladenburg Thalmann Healthcare Conference
FORT LAUDERDALE, Fla., June 29, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Brickell Biotech Announces Final Patient Completed in First U.S. Phase 3 Pivotal Clinical Study and Patient Enrollment Completed in Second U.S. Phase 3 Pivotal Clinical Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
Topline results for Phase 3 Pivotal Cardigan I and Cardigan II studies expected in Q4…
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
— Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million —…
Bioasis Technologies Announces Closing of Initial C$3,000,000 Funding by Lind Partners
NEW HAVEN, Conn., June 29, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (“Bioasis” or the…
Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia
UNIONDALE, N.Y., June 29, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical…
Akari Therapeutics Reports Q1 2021 Financial Results and Highlights Recent Clinical Progress
Open Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase…
Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial
AdCOVID was well tolerated but did not stimulate an adequate immune response in healthy volunteers…
Iovance Biotherapeutics to Host Conference Call and Webcast to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer on June 29, 2021 at 4:30pm ET
SAN CARLOS, Calif., June 29, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Segra International completes first export of Cannabis plantlets from Canada to the USA
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a leading cannabis…
BioAegis Awarded BARDA Contract to Advance Development of Gelsolin, a Novel Host-Directed Human Protein, for Patients with Sepsis and Severe Infection
NORTH BRUNSWICK, N.J., June 29, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage,…
Lowell Farms Commissioning First-of-its-Kind Cannabis Processing Facility in Salinas Valley
Facility capable of processing 250,000 lbs. of wholesale cannabis flower annually Commissioning Lowell Farms Services,…
Adocia Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes
For the first time, a unique combination of two key hormones involved in glycemic control,…
Adocia Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes
For the first time, a unique combination of two key hormones involved in glycemic control,…
FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary Cancer
Company reaches important milestone to advance potential novel therapy for this subset of gastrointestinal cancers…
Todos Medical Provides End of Second Quarter 2021 Corporate Update
Tollovir™ COVID-19 anti-viral scientific and clinical development progressing in Israel with plans progressing rapidly to…